Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9164)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 7, 2020 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cheng QC, Fan J, Deng XW, Liu HC, Ding HR, Fang X, Wang JW, Chen CH, Zhang WG. Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis. World J Gastroenterol 2020; 26(41): 6346-6360 [PMID: 33244197 DOI: 10.3748/wjg.v26.i41.6346] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i41/6346.htm |
| Number | Citing Articles |
| 1 |
Asmaa I. Matouk, Eman M. Awad, Nashwa F.G. El-Tahawy, Azza A.K. El-Sheikh, Shaimaa Waz. Dihydromyricetin alleviates methotrexate-induced hepatotoxicity via suppressing the TLR4/NF-κB pathway and NLRP3 inflammasome/caspase 1 axis. Biomedicine & Pharmacotherapy 2022; 155: 113752 doi: 10.1016/j.biopha.2022.113752
|
| 2 |
Rui Qiang, Yanbo Li, Xincan Dai, Wenliang Lv. NLRP3 inflammasome in digestive diseases: From mechanism to therapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.978190
|
| 3 |
Yang Sun, Shasha Liu, Songwei Yang, Chen Chen, Yantao Yang, Meiyu Lin, Chao Liu, Wenmao Wang, Xudong Zhou, Qidi Ai, Wei Wang, Naihong Chen. Mechanism of Dihydromyricetin on Inflammatory Diseases. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.794563
|
| 4 |
Haochen Wang, Jianbang Su, Minghao Yu, Yang Xia, Yingliang Wei. PGC-1α in osteoarthritic chondrocytes: From mechanism to target of action. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1169019
|
| 5 |
Shuai Shao, Yu Zhang, Guantong Li, Zhenjun Yu, Yingying Cao, Lina Zheng, Kun Zhang, Xiaohui Han, Zhemin Shi, Hongmei Cui, Xiaomeng Song, Wei Hong, Tao Han. The dynamics of cell death patterns and regeneration during acute liver injury in mice. FEBS Open Bio 2022; 12(5): 1061 doi: 10.1002/2211-5463.13383
|
| 6 |
Wenxing He, Canli Xu, Dewen Mao, Yang Zheng, Na Wang, Minggang Wang, Nan Mao, Ting Wang, Yanjie Li. Recent advances in pyroptosis, liver disease, and traditional Chinese medicine: A review. Phytotherapy Research 2023; 37(12): 5473 doi: 10.1002/ptr.7989
|
| 7 |
Tong Guo, Xitong Wang, Gensheng Zhang, Tian Xia, Runzhi Zhu, Jinfa Tou. Dihydromyricetin functions as a tumor suppressor in hepatoblastoma by regulating SOD1/ROS pathway. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1160548
|
| 8 |
Xinzhang Chen, Zhiheng Zhang, Meilun Shen, Xiangying Ma, Di Qiu, Siyao Li, Li Gao. Downregulation of the NLRP3/Caspse-1 Pathway Ameliorates Ketamine-Induced Liver Injury and Inflammation in Developing Rats. Molecules 2022; 27(9): 2931 doi: 10.3390/molecules27092931
|
| 9 |
Jingwen Wu, Mingyu Zhang, Suhong Xia, Ping Han, Kai Zhao, Kaixin Peng, Wangdong Zhou, Dean Tian, Jiazhi Liao, Jingmei Liu. Hepatic HRC induces hepatocyte pyroptosis and HSCs activation via NLRP3/caspase-1 pathway. Journal of Molecular Medicine 2022; 100(12): 1787 doi: 10.1007/s00109-022-02270-8
|
| 10 |
Jing Lu, Ziheng Chen, Xiujuan Bu, Shanshan Chen, Shuang Guan. Elaidic acid induced hepatocyte pyroptosis via autophagy-CTSB-NLRP3 pathway. Food and Chemical Toxicology 2023; 181: 114060 doi: 10.1016/j.fct.2023.114060
|
| 11 |
Panpan Cao, Gaohui Nie, Junrong Luo, Ruiming Hu, Guyue Li, Guoliang Hu, Caiying Zhang. Cadmium and molybdenum co-induce pyroptosis and apoptosis via the PTEN/PI3K/AKT axis in the livers of Shaoxing ducks (Anas platyrhynchos). Food & Function 2022; 13(4): 2142 doi: 10.1039/D1FO02855C
|
| 12 |
Ruohong Chen, Yingyi Lian, Shuai Wen, Qiuhua Li, Lingli Sun, Xingfei Lai, Zhenbiao Zhang, Junquan Zhu, Linsong Tang, Ji Xuan, Erdong Yuan, Shili Sun. Shibi Tea (Adinandra nitida) and Camellianin A Alleviate CCl4-Induced Liver Injury in C57BL-6J Mice by Attenuation of Oxidative Stress, Inflammation, and Apoptosis. Nutrients 2022; 14(15): 3037 doi: 10.3390/nu14153037
|
| 13 |
Qiteng Ding, Xinglong Liu, Shuai Zhang, Guodong Chai, Shuang Ma, Shuwen Sun, Liqian Shen, Yang Gao, Chuanbo Ding, Ting Zhao, Wencong Liu. Chitosan-modified dihydromyricetin liposomes promote the repair of liver injury in mice suffering from diabetes mellitus. International Journal of Biological Macromolecules 2024; 273: 133040 doi: 10.1016/j.ijbiomac.2024.133040
|
| 14 |
Hao Wang, Jinhang Zhou, Wenxin Shi, Shijuan Shao, Yunzhong Chen. Modulatory Effect of Dihydromyricetin on Chronic Alcoholic Liver Injury Based on the FXR-NLRP3 Signaling Pathway and Serum and Liver Metabolomics. Natural Product Communications 2024; 19(5) doi: 10.1177/1934578X241250254
|
| 15 |
Yirong Wang, Junmin Wang, Hongjiao Xiang, Peilun Ding, Tao Wu, Guang Ji. Recent update on application of dihydromyricetin in metabolic related diseases. Biomedicine & Pharmacotherapy 2022; 148: 112771 doi: 10.1016/j.biopha.2022.112771
|
| 16 |
Jingnan Chen, Xitong Wang, Tian Xia, Yanhua Bi, Bin Liu, Junfen Fu, Runzhi Zhu. Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease. Biomedicine & Pharmacotherapy 2021; 142: 111927 doi: 10.1016/j.biopha.2021.111927
|
| 17 |
Lu Liu, Sen Sun, Xiaohua Li. A network pharmacology-based approach to explore the effect of dihydromyricetin on non-alcoholic fatty liver rats via regulating PPARG and CASP3. Molecular and Cellular Probes 2023; 71: 101926 doi: 10.1016/j.mcp.2023.101926
|